Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma.

Laura-Sophie Landwehr Barbara AltieriIuliu SbieraHanna RemdeStefan KircherJulie Olabe Silviu Sbiera Matthias Kroiss Fassnacht Martin

Published in: The Journal of clinical endocrinology and metabolism (2024)

The heterogeneous expression of PD1, PD-L1, and CTLA-4 in this large series of well-annotated ACC samples might explain the heterogeneous results of the immunotherapies in advanced ACC. In addition, PD-1 expression is a strong prognostic biomarker that can easily be applied in routine clinical care and histopathological assessment.

Keyphrases

poor prognosis
healthcare
palliative care
long non coding rna
chronic pain
pain management